INO logo

Inovio Pharmaceuticals (INO)

Profile

Full Name

Inovio Pharmaceuticals, Inc.

Ticker Symbol

INO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 8, 1998

Indexes

Not included

Website

http://www.inovio.com

Employees

134

Key Details

Price

$1.74(+1.16%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$217.80K(-73.82% YoY)

Annual EPS

-$3.95(+35.14% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.74
INO price is $1.74

30-Day Relative Volume

0.45
INO 30-day relative volume is 0.45

Price Performance

Price Most recent change

+1.16%
INO price was up +1.16% on Apr 17, 2025

Price YTD change

-4.92%
INO price is down -4.92% since January 1st

Price 1-year change

-84.28%
INO price is down -84.28% year-on-year

Price 3-year change

-95.47%
INO price is down -95.47% over the past 3 years

Price Range

Price All-time high

$2352.00
INO price is currently -99.93% below its historical high of $2352.00

Price 3-year low

$1.42
INO price is currently +22.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$63.80M
INO market capitalization is $63.80 million

Market cap 3-year change

-91.2%
INO market capitalization is down -91.2% over the past 3 years

Market cap All-time high

$5.01B
INO market capitalization is currently -98.73% below its historical high of $5.01 billion

Market cap sector rank

41.89%
INO market capitalization is higher than 41.89% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+56.89%
INO shares outstanding is up +56.89% year-on-year

Shares Outstanding 3-Year Change

+94.25%
INO shares outstanding is up +94.25% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.08
INO beta is 1.08

200-day SMA

$4.72
INO price is currently -63.14% below its 200-day simple moving average

50-day SMA

$1.89
INO price is currently -7.69% below its 50-day simple moving average

RSI

49.27
INO 14-day relative strength index is 49.27

Volume

0.45
INO 30-day relative volume is 0.45

ATR

$0.11
INO average true range is $0.11

10-day Historical Volatility

82.17%
INO 10-day historical volatility is 82.17%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$217.80K
INO annual revenue is $217.80 thousand

Revenue Analysts estimate

$2.57M
INO annual revenue is currently -91.51% lower than the consensus analysts' forecast

Revenue 1-year change

-73.82%
INO annual revenue is down -73.82% year-on-year

Revenue Sector rank

7.51%
INO annual revenue is higher than 7.51% of companies in Healthcare sector

EPS

EPS

-$3.95
INO annual earnings per share is -$3.95

EPS Analysts estimate

-$2.61
INO annual earnings per share is currently +51.11% higher than the consensus analysts' forecast

EPS 1-year change

+35.14%
INO annual earnings per share is up +35.14% year-on-year

EPS Sector rank

22.95%
INO annual earnings per share is higher than 22.95% of companies in Healthcare sector

Profit

Gross profit

-
INO annual gross profit value is unknown

Gross margin

-
INO annual gross profit margin value is unknown

Operating profit

-$112.40M
INO annual operating income is -$112.40 million

Operating margin

-51.62K%
INO annual operating profit margin is -51.62 thousand%

Net income

-$107.25M
INO annual net profit is -$107.25 million

Net margin

-49.25K%
INO annual net profit margin is -49.25 thousand%

Expenses

Total expenses

$112.62M
INO annual total expenses is $112.62 million

Operating expenses

$112.62M
INO annual total operating expenses is $112.62 million

Cost of goods sold

-
INO annual cost of goods sold value is unknown

Selling, general & administrative expenses

$37.00M
INO annual SGA is $37.00 million

Depreciation and amortization

$3.13M
INO annual depreciation & amortization is $3.13 million

Interest expense

$177.80K
INO annual interest expense is $177.80 thousand

Income tax

-
INO annual income tax value is unknown

EBIT & EBITDA

EBIT

-$107.08M
INO annual earnings before interest & taxes is -$107.08 million

EBITDA

-$103.95M
INO annual EBITDA is -$103.95 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$113.20M
INO annual total assets is $113.20 million

Non current assets

$15.37M
INO annual long term assets is $15.37 million

Current assets

$97.83M
INO annual total current assets is $97.83 million

Cash and cash equivalents

$65.81M
INO annual cash & cash equivalents is $65.81 million

Accounts receivable

-
INO annual accounts receivable value is unknown

Inventory

-
INO annual inventory value is unknown

Liabilities

Total liabilities

$44.69M
INO annual total liabilities is $44.69 million

Long term liabilities

$9.37M
INO annual total long term liabilities is $9.37 million

Current liabilities

$35.33M
INO annual total current liabilities is $35.33 million

Accounts payable

$6.44M
INO annual accounts payable is $6.44 million

Debt

Total debt

$11.87M
INO annual total debt is $11.87 million

Total debt 1-year change

-60.72%
INO annual total debt is down -60.72% year-on-year

Long term debt

$9.37M
INO annual long term debt is $9.37 million

Short term debt

$2.50M
INO annual short term debt is $2.50 million

Equity & Capital

Shareholders equity

$68.50M
INO annual stockholders equity is $68.50 million

Book value

$68.50M
INO annual book value is $68.50 million

Retained earnings

-$1.73B
INO annual retained earnings is -$1.73 billion

Working capital

$62.50M
INO annual working capital is $62.50 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$104.08M
INO annual cash flow from operations is -$104.08 million

Cash from operations 1-year change

+16.31%
INO annual cash flow from operations is up +16.31% year-on-year

Cash from investing

$104.07M
INO annual cash flow from investing activities is $104.07 million

Cash from investing 1-year change

+19.13%
INO annual cash flow from investing activities is up +19.13% year-on-year

Cash from financing

$51.48M
INO annual cash flow from financing activities is $51.48 million

Cash from financing 1-year change

+930.52%
INO annual cash flow from financing activities is up +930.52% year-on-year

CAPEX

CAPEX

$487.80K
INO annual capital expenditures is $487.80 thousand

CAPEX 1-year change

+52.01%
INO annual capital expenditures is up +52.01% year-on-year

Free Cash Flow

Free cash flow

-$104.56M
INO annual free cash flow is -$104.56 million

Free cash flow 1-year change

+16.14%
INO annual free cash flow is up +16.14% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
INO annual gross profit margin value is unknown

Operating margin

-51.62K%
INO annual operating profit margin is -51.62 thousand%

Net margin

-49.25K%
INO annual net profit margin is -49.25 thousand%

ROA & ROE

ROA

-75.49%
INO annual return on assets is -75.49%

ROE

-115.42%
INO annual return on equity is -115.42%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
INO price to earnings ratio value is unknown

PE ratio Sector rank

-
INO price to earnings ratio is unknown

PB Ratio

PB ratio

0.93
INO price to book ratio is 0.93

PB ratio Sector rank

42.62%
INO price to book ratio is higher than 42.62% of companies in Healthcare sector

PS Ratio

PS ratio

292.93
INO price to sales ratio is 292.93

PS ratio Sector rank

96.92%
INO price to sales ratio is higher than 96.92% of companies in Healthcare sector

Enterprise value

Enterprise value

$9.85M
INO enterprise value is $9.85 million

Enterprise value Sector rank

24.71%
INO enterprise value is higher than 24.71% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.09
INO EV/EBITDA is -0.09

EV/EBITDA Sector rank

62.23%
INO EV/EBITDA is higher than 62.23% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.77
INO annual current ratio is 2.77

Quick ratio

-
INO annual quick ratio value is unknown

Leverage

Debt to equity

0.00
INO annual debt to equity ratio is 0.00

Interest coverage ratio

-602.23
INO annual interest coverage ratio is -602.23

Risk & Stability

Piotroski F-Score

-
INO piotroski f-score value is unknown

Altman Z-Score

-23.00
INO altman z-score is -23.00

Analyst ratings

Recent major analysts updates

Mar 19, 25 RBC Capital
Sector Perform
Mar 19, 25 HC Wainwright & Co.
Neutral
Jan 13, 25 HC Wainwright & Co.
Neutral
Jan 10, 25 JMP Securities
Market Outperform
Nov 18, 24 Oppenheimer
Outperform
Nov 18, 24 HC Wainwright & Co.
Neutral
Nov 15, 24 RBC Capital
Sector Perform
Aug 12, 24 Oppenheimer
Outperform
Aug 9, 24 RBC Capital
Sector Perform
Jul 15, 24 HC Wainwright & Co.
Neutral

Institutional Ownership

Similar stocks

PETS logo
PetMed Express (PETS)
BMEA logo
Biomea Fusion (BMEA)
YI logo
111 (YI)
CTSO logo
Cytosorbents (CTSO)
ANL logo
Adlai Nortye American Depositary Shares (ANL)
MCRB logo
Seres Therapeutics (MCRB)
VANI logo
Vivani Medical (VANI)
INCR logo
InterCure (INCR)
XTNT logo
Xtant Medical Holdings (XTNT)
  • What is the ticker symbol for Inovio Pharmaceuticals?
  • Does Inovio Pharmaceuticals pay dividends?
  • What sector is Inovio Pharmaceuticals in?
  • What industry is Inovio Pharmaceuticals in?
  • What country is Inovio Pharmaceuticals based in?
  • When did Inovio Pharmaceuticals go public?
  • Is Inovio Pharmaceuticals in the S&P 500?
  • Is Inovio Pharmaceuticals in the NASDAQ 100?
  • Is Inovio Pharmaceuticals in the Dow Jones?
  • When was Inovio Pharmaceuticals's last earnings report?
  • When does Inovio Pharmaceuticals report earnings?
  • Should I buy Inovio Pharmaceuticals stock now?

What is the ticker symbol for Inovio Pharmaceuticals?

The ticker symbol for Inovio Pharmaceuticals is NASDAQ:INO

Does Inovio Pharmaceuticals pay dividends?

No, Inovio Pharmaceuticals does not pay dividends

What sector is Inovio Pharmaceuticals in?

Inovio Pharmaceuticals is in the Healthcare sector

What industry is Inovio Pharmaceuticals in?

Inovio Pharmaceuticals is in the Biotechnology industry

What country is Inovio Pharmaceuticals based in?

Inovio Pharmaceuticals is headquartered in United States

When did Inovio Pharmaceuticals go public?

Inovio Pharmaceuticals's initial public offering (IPO) was on December 8, 1998

Is Inovio Pharmaceuticals in the S&P 500?

No, Inovio Pharmaceuticals is not included in the S&P 500 index

Is Inovio Pharmaceuticals in the NASDAQ 100?

No, Inovio Pharmaceuticals is not included in the NASDAQ 100 index

Is Inovio Pharmaceuticals in the Dow Jones?

No, Inovio Pharmaceuticals is not included in the Dow Jones index

When was Inovio Pharmaceuticals's last earnings report?

Inovio Pharmaceuticals's most recent earnings report was on Mar 18, 2025

When does Inovio Pharmaceuticals report earnings?

The next expected earnings date for Inovio Pharmaceuticals is May 13, 2025

Should I buy Inovio Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page